DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Doxylamine Succinate is a drug marketed by Copley Pharm, LNK, Perrigo, Quantum Pharmics, Actavis Labs Fl Inc, Mylan Pharms Inc, and Par Pharm Inc. and is included in seven NDAs.
The generic ingredient in DOXYLAMINE SUCCINATE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.
A generic version of DOXYLAMINE SUCCINATE was approved as doxylamine succinate; pyridoxine hydrochloride by ACTAVIS LABS FL INC on August 19th, 2016.
Recent Clinical Trials for DOXYLAMINE SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
|Grünenthal, S.A.||Phase 1|
|Grünenthal GmbH||Phase 1|
|Azidus Brasil||Phase 3|